1. Home
  2. AN vs ADPT Comparison

AN vs ADPT Comparison

Compare AN & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AutoNation Inc.

AN

AutoNation Inc.

N/A

Current Price

$155.41

Market Cap

5.4B

ML Signal

N/A

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$26.37

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AN
ADPT
Founded
1991
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
4.5B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
AN
ADPT
Price
$155.41
$26.37
Analyst Decision
Buy
Strong Buy
Analyst Count
13
9
Target Price
★ $233.33
$28.31
AVG Volume (30 Days)
621.9K
★ 2.3M
Earning Date
10-22-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
0.71
★ 63.89
EPS
★ 11.26
N/A
Revenue
★ $27,631,400,000.00
$276,976,000.00
Revenue This Year
$0.41
$5.94
Revenue Next Year
$3.53
$22.42
P/E Ratio
$14.02
★ N/A
Revenue Growth
3.24
★ 54.77
52 Week Low
$153.46
$12.00
52 Week High
$235.81
$30.74

Technical Indicators

Market Signals
Indicator
AN
ADPT
Relative Strength Index (RSI) 27.93 46.85
Support Level N/A $23.73
Resistance Level $213.29 $26.51
Average True Range (ATR) 8.01 1.44
MACD -1.01 -0.26
Stochastic Oscillator 4.25 9.13

Price Performance

Historical Comparison
AN
ADPT

About AN AutoNation Inc.

AutoNation is the second-largest automotive dealer in the United States, with 2025 revenue of $27.6 billion and over 245 dealerships, plus 52 collision centers. The firm also has 24 AutoNation USA used-vehicle stores, a captive lender, four auction sites, and three parts distributors across 20 states primarily in Sunbelt metropolitan areas. New-vehicle sales account for nearly half of revenue; the company also sells used vehicles, parts, and repair services as well as auto financing. The company (formerly Republic Industries) divested its waste management unit (Republic Services) in 1999 and its car rental businesses (ANC Rental) in 2000. Wayne Huizenga founded the company in the 1990s to bring the rollup acquisition strategy to auto retailing, which proved to be a smart move.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Share on Social Networks: